Drug Shortage Report for EMEND IV
Report ID | 144168 |
Drug Identification Number | 02363356 |
Brand name | EMEND IV |
Common or Proper name | fosaprepitant for injection |
Company Name | MERCK CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | FOSAPREPITANT |
Strength(s) | 150MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 150MG 1DOSE LOW EDTA VIAL |
ATC code | A04AD |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2021-08-27 |
Actual start date | 2021-08-27 |
Estimated end date | 2021-09-03 |
Actual end date | 2021-08-30 |
Shortage status | Resolved |
Updated date | 2021-08-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2021-08-31 | French | Compare |
v7 | 2021-08-30 | French | Compare |
v6 | 2021-08-30 | English | Compare |
v5 | 2021-08-28 | English | Compare |
v4 | 2021-08-27 | English | Compare |
v3 | 2021-08-16 | French | Compare |
v2 | 2021-08-16 | English | Compare |
v1 | 2021-08-16 | English | Compare |
Showing 1 to 8 of 8